Ligand · A1H07
A1H07 · ~{N}-[[(4~{R})-4-cyclopropyl-2,5-bis(oxidanylidene)imidazolidin-4-yl]methyl]-2-(3-fluorophenyl)-1,2,3-triazole-4-carboxamide
A1H07, ~{N}-[[(4~{R})-4-cyclopropyl-2,5-bis(oxidanylidene)imidazolidin-4-yl]methyl]-2-(3-fluorophenyl)-1,2,3-triazole-4-carboxamide (C16 H15 F N6 O3, 358.3 g/mol), in the MolNFT structures on GenesisL1: bound in 1 record (1 PDB entry).…
- Component
- A1H07
- Formula
- C16 H15 F N6 O3
- Class
- ligand
- Structures
- 1
- PDB entries
- 1
Binding sites
A1H07 in 1 structure; the first of them:
- 8RIJ · Discovery of the first orally bioavailable ADAMTS7 inhibitor BAY-9835 · A1H07 A306 · binds ILE180, LEU181, ALA182, HIS183, LEU214, THR215, HIS218, GLU219 and 7 more
Residues it binds most
HIS 1, LEU 1, THR 1, ALA 1, GLU 1, ILE 1, PHE 1, PRO 1, TYR 1, VAL 1 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.